Funding Received
$30.4 Million in 3 Rounds from 4 Investors
Most Recent Funding
$20 Million Series B on September 3, 2013
Founded:
2010
Headquarters:
Vienna
Description:
Arsanis is a biosciences company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.
Founders:
Errik B. Anderson, Tillman Gerngross
Categories:
Biotechnology
Website:
http://www.arsanis.com

Detailed Description

Update

Arsanis, Inc. was incorporated in 2010 and is based in Lebanon, New Hampshire. Arsanis also operates as Arsanis Biosciences in Vienna, Austria, and according to a job posting, the company is focused on developing infectious disease treatments based on similar bacterial protein and carbohydrate antigens as GlycoFi.

Current Team (10)

Update

Funding Rounds (3) - $30.4M

Update

Board Members and Advisors (4)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Campus Vienna Biocenter 4

    Dr. Bohr-Gasse 3

    Vienna, A-1030

    AUT